CCL7 and rheumatoid arthritis: In this double-blind, placebo-controlled, proof-of-concept clinical trial, the effect of adalimumab in combination with MTX vs. MTX monotherapy on joint cartilage integrity of MCP2 and MCP3 in patients with early RA was examined with compositional MRI of the cartilage by using dGEMRIC [24].